Global Companion Diagnostic Market Growth (Status and Outlook) 2023-2029

Global Companion Diagnostic Market Growth (Status and Outlook) 2023-2029

A companion diagnostic device is a special type of invitro medical device that provides information, which is necessary for the effective and safe use of an analogous drug or biological product. Companion diagnostics are developed simultaneously with drugs to help include or exclude a certain group of patients for treatment with a particular drug based on their biological characteristics, which determines patients who respond and those who dont respond to the therapy.

LPI (LP Information)' newest research report, the “Companion Diagnostic Industry Forecast” looks at past sales and reviews total world Companion Diagnostic sales in 2022, providing a comprehensive analysis by region and market sector of projected Companion Diagnostic sales for 2023 through 2029. With Companion Diagnostic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Companion Diagnostic industry.

This Insight Report provides a comprehensive analysis of the global Companion Diagnostic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Companion Diagnostic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Companion Diagnostic market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Companion Diagnostic and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Companion Diagnostic.

The global Companion Diagnostic market size is projected to grow from US$ 8628.2 million in 2022 to US$ 32780 million in 2029; it is expected to grow at a CAGR of 21.0% from 2023 to 2029.

United States market for Companion Diagnostic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Companion Diagnostic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Companion Diagnostic is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Companion Diagnostic players cover Roche Holdings, Abbott Laboratories, Thermo Fisher Scientific, Agilent Technologies, Merck, Agendia, Qiagen, Myriad Genetics and Advanced Cell Diagnostics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Companion Diagnostic market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Immunohistochemistry
Molecular Diagnosis

Segmentation by application
Oncology
Cardiovascular
Central Nervous System
Virology
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Roche Holdings
Abbott Laboratories
Thermo Fisher Scientific
Agilent Technologies
Merck
Agendia
Qiagen
Myriad Genetics
Advanced Cell Diagnostics
Danaher
Illumina, Inc

Please note: The report will take approximately 2 business days to prepare and deliver.